IT1246511B - Agenti bloccanti dell'effetto di edrf o della formazione di edrf per il trattamento di stati di shock - Google Patents

Agenti bloccanti dell'effetto di edrf o della formazione di edrf per il trattamento di stati di shock

Info

Publication number
IT1246511B
IT1246511B IT02241390A IT2241390A IT1246511B IT 1246511 B IT1246511 B IT 1246511B IT 02241390 A IT02241390 A IT 02241390A IT 2241390 A IT2241390 A IT 2241390A IT 1246511 B IT1246511 B IT 1246511B
Authority
IT
Italy
Prior art keywords
edrf
training
treatment
effect
blocking agents
Prior art date
Application number
IT02241390A
Other languages
English (en)
Italian (it)
Other versions
IT9022413A1 (it
IT9022413A0 (it
Inventor
Pierre Braquet
De Lassauniere Pierre Chabrier
Jean-Michel Guillon
Original Assignee
Sod Conseils Rech Applic
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sod Conseils Rech Applic filed Critical Sod Conseils Rech Applic
Publication of IT9022413A0 publication Critical patent/IT9022413A0/it
Publication of IT9022413A1 publication Critical patent/IT9022413A1/it
Application granted granted Critical
Publication of IT1246511B publication Critical patent/IT1246511B/it

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A61K31/197—Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid or pantothenic acid
    • A61K31/198—Alpha-amino acids, e.g. alanine or edetic acid [EDTA]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P39/00—General protective or antinoxious agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/02—Non-specific cardiovascular stimulants, e.g. drugs for syncope, antihypotensives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Toxicology (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
  • Polyurethanes Or Polyureas (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
IT02241390A 1989-12-22 1990-12-18 Agenti bloccanti dell'effetto di edrf o della formazione di edrf per il trattamento di stati di shock IT1246511B (it)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB898929076A GB8929076D0 (en) 1989-12-22 1989-12-22 Treatment of shock by blocking agents of edrf effect or formation

Publications (3)

Publication Number Publication Date
IT9022413A0 IT9022413A0 (it) 1990-12-18
IT9022413A1 IT9022413A1 (it) 1991-06-23
IT1246511B true IT1246511B (it) 1994-11-19

Family

ID=10668428

Family Applications (1)

Application Number Title Priority Date Filing Date
IT02241390A IT1246511B (it) 1989-12-22 1990-12-18 Agenti bloccanti dell'effetto di edrf o della formazione di edrf per il trattamento di stati di shock

Country Status (21)

Country Link
US (1) US5081148A (enEXAMPLES)
JP (1) JP2706578B2 (enEXAMPLES)
KR (1) KR950005866B1 (enEXAMPLES)
AT (1) AT403122B (enEXAMPLES)
AU (1) AU629777B2 (enEXAMPLES)
BE (1) BE1005531A5 (enEXAMPLES)
CA (1) CA2032904C (enEXAMPLES)
CH (1) CH681692A5 (enEXAMPLES)
DE (1) DE4041283C2 (enEXAMPLES)
DK (1) DK176168B1 (enEXAMPLES)
FR (1) FR2656220B1 (enEXAMPLES)
GB (2) GB8929076D0 (enEXAMPLES)
HK (1) HK134693A (enEXAMPLES)
IE (1) IE64403B1 (enEXAMPLES)
IT (1) IT1246511B (enEXAMPLES)
LU (1) LU87867A1 (enEXAMPLES)
MY (1) MY105328A (enEXAMPLES)
NL (1) NL194717C (enEXAMPLES)
OA (1) OA09337A (enEXAMPLES)
SE (1) SE504922C2 (enEXAMPLES)
ZA (1) ZA9010004B (enEXAMPLES)

Families Citing this family (33)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE468881B (sv) * 1991-01-09 1993-04-05 Kabi Pharmacia Ab Anvaendning av vissa foereningar foer framstaellning av laekemedel foer behandling av endotoxininducerade effekter samt saett att avlaegsna endotoxiner ur diverse loesningar
GB9127376D0 (en) * 1991-12-24 1992-02-19 Wellcome Found Amidino derivatives
GB9200114D0 (en) * 1992-01-04 1992-02-26 Scras Dual inhibitors of no synthase and cyclooxygenase
US5385940A (en) * 1992-11-05 1995-01-31 The General Hospital Corporation Treatment of stroke with nitric-oxide releasing compounds
US5585402A (en) * 1992-12-23 1996-12-17 Glaxo Wellcome Inc. Nitric oxide synthase inhibitors
US5436270A (en) * 1993-04-07 1995-07-25 National Science Council Method for protecting against endotoxin-induced shock
GB9312204D0 (en) * 1993-06-14 1993-07-28 Zeneca Ltd Therapeutic composition
GB9312761D0 (en) * 1993-06-21 1993-08-04 Wellcome Found Amino acid derivatives
US6297276B1 (en) 1993-10-04 2001-10-02 Glaxosmithkline Substituted urea and isothiourea derivatives as no synthase inhibitors
US6090846A (en) * 1994-06-01 2000-07-18 Glaxo Wellcome Inc. Substituted urea and isothiourea derivatives as no synthase inhibitors
US6225305B1 (en) 1993-10-04 2001-05-01 Glaxo Wellcome Inc. Substituted urea and isothiorea derivatives as no synthase inhibitors
ES2181726T3 (es) * 1993-10-21 2003-03-01 Searle & Co Amidinoderivados utiles como inhibidores de oxido nitrico sintasa.
ATE177078T1 (de) * 1993-10-21 1999-03-15 Searle & Co Amidino-derivate als no-synthetase inhibitoren
GB9404400D0 (en) * 1994-03-07 1994-04-20 Wood Pauline J Potentiation of bioreductive agents
DE69518631T2 (de) * 1994-03-10 2001-01-11 G.D. Searle & Co., Chicago L-n6-(1-iminoethyl)lysin - derivate und ihre verwendung als no-synthase - inhibitoren
US5684008A (en) * 1994-11-09 1997-11-04 G. D. Searle & Co. Aminotetrazole derivatives useful as nitric oxide synthase inhibitors
FR2727111B1 (fr) * 1994-11-21 1997-01-17 Hoechst Lab Nouveaux analogues soufres d'aminoacides, leur procede de preparation et leurs applications comme medicaments
CA2206119C (en) * 1994-12-12 2008-05-13 Omeros Medical Systems, Inc. Irrigation solution and method for inhibition of pain, inflammation and spasm
KR100517210B1 (ko) * 1994-12-12 2006-06-07 오메로스 코포레이션 통증,염증및경련억제용관주용액
FR2730930B1 (fr) 1995-02-27 1997-04-04 Oreal Utilisation d'inhibiteurs de no-synthase pour diminuer l'effet irritant cutane de produits utilises dans le domaine cosmetique ou pharmaceutique
GB9504350D0 (en) * 1995-03-04 1995-04-26 Sod Conseils Rech Applic Arginine derivatives
CN1105706C (zh) * 1995-04-20 2003-04-16 G·D·瑟尔公司 用作氧化氮合成酶抑制剂的环状脒基制剂
US5830917A (en) * 1995-09-11 1998-11-03 G. D. Searle & Co. L-N6 -(1-iminoethyl) lysine derivatives useful as nitric oxide synthase inhibitors
BR9509985A (pt) * 1995-12-12 1998-11-03 Omeros Med Sys Inc Solução para irrigação e método para inibição de dor inflamação e esparmo
US5945408A (en) * 1996-03-06 1999-08-31 G.D. Searle & Co. Hydroxyanidino derivatives useful as nitric oxide synthase inhibitors
US5981511A (en) * 1996-03-06 1999-11-09 G.D. Searle & Co. Hydroxyamidino derivatives useful as nitric oxide synthase inhibitors
US6620848B2 (en) 1997-01-13 2003-09-16 Smithkline Beecham Corporation Nitric oxide synthase inhibitors
US6369272B1 (en) 1997-01-13 2002-04-09 Glaxosmithkline Nitric oxide synthase inhibitors
US5981556A (en) * 1997-07-22 1999-11-09 G.D. Searle & Co. 1,3-diazolino and 1,3-diazolidino heterocycles as useful nitric oxide synthase inhibitors
GB9811599D0 (en) 1998-05-30 1998-07-29 Glaxo Group Ltd Nitric oxide synthase inhibitors
JP2002517502A (ja) 1998-06-10 2002-06-18 ジー・ディー・サール・アンド・カンパニー 複素二環状及び三環状一酸化窒素シンターゼ阻害剤
US6344473B1 (en) 2000-08-07 2002-02-05 G.D. Searle & Co. Imidazoles useful as nitric oxide synthase inhibitors
WO2005063752A1 (en) 2003-12-30 2005-07-14 Vasopharm Biotech Gmbh 4-amino-7,8-dihydropteridines, pharmaceutical compositions containing them and their use for the treatment of diseases which are caused by an increased nitric oxide level

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB931921A (en) * 1960-12-22 1963-07-24 Lab Roques Therapeutic compositions intended for the treatment of any hepatic malfunctionings
DE1767212B1 (de) * 1967-04-13 1971-05-06 Sumitomo Chemical Co Verfahren zur Herstellung injizierbarer Arzneimittel
FR2115060A1 (en) * 1970-11-26 1972-07-07 Metabio Freeze-dried acetylsalicylates of lysine and arginine - easily prepd derivs of aspirin
CA1029660A (en) * 1973-06-01 1978-04-18 Kyowa Hakko Kogyo Co. Prevention of gastric lesions
FR2320759A1 (fr) * 1975-08-11 1977-03-11 Union Pharma Scient Appl Solution d'acide acetylsalicylique extemporanee injectable
IT1127321B (it) * 1979-12-28 1986-05-21 Italfarmaco Spa Composizione farmaceutiche aventi specifiche proprieta' terapeutiche nei confronti dell'edema polmonare acuto,di alcuni stati di shock e dell'iperfibrinolisi
IT1127322B (it) * 1979-12-28 1986-05-21 Italfarmaco Spa Composizioni farmaceutiche con esaltazione dell'attivita' terapeutica di cortisonici
JPS5781409A (en) * 1980-11-10 1982-05-21 Toko Yakuhin Kogyo Kk External plaster
JPS57197211A (en) * 1981-05-28 1982-12-03 Sumitomo Chem Co Ltd Useful eye drop composition
JPS57200361A (en) * 1981-06-03 1982-12-08 Sumitomo Chem Co Ltd "indomethacin(r)" pharmaceutical with low irritant action
JPS6239524A (ja) * 1985-08-13 1987-02-20 Toko Yakuhin Kogyo Kk 消炎鎮痛軟膏剤
JPH0236570B2 (ja) * 1985-05-30 1990-08-17 Toko Yakuhin Kogyo Kk Shoenchintsunankozai
IT1201511B (it) * 1985-12-23 1989-02-02 Italfarmaco Spa Derivati citoprotettivi in patologie a base ischemica,loro preparazione e composizioni che li cntengono
DE3878812T2 (de) * 1987-02-20 1993-07-22 Shriners Hospitals For Cripple Omega-3-fettsaeuren zur behandlung von traumatischen verwundungen.

Also Published As

Publication number Publication date
BE1005531A5 (fr) 1993-09-28
JP2706578B2 (ja) 1998-01-28
DK304190D0 (da) 1990-12-21
IT9022413A1 (it) 1991-06-23
GB2240041B (en) 1993-09-01
IE904592A1 (en) 1991-07-03
KR910011253A (ko) 1991-08-07
DE4041283A1 (de) 1991-06-27
FR2656220B1 (fr) 1995-01-13
FR2656220A1 (fr) 1991-06-28
DE4041283C2 (de) 2000-07-13
ZA9010004B (en) 1991-10-30
LU87867A1 (fr) 1991-05-07
NL194717C (nl) 2003-01-07
KR950005866B1 (ko) 1995-06-02
AU6837690A (en) 1991-06-27
AT403122B (de) 1997-11-25
GB9028013D0 (en) 1991-02-13
CA2032904C (en) 1996-01-02
CH681692A5 (enEXAMPLES) 1993-05-14
IT9022413A0 (it) 1990-12-18
GB2240041A (en) 1991-07-24
SE9003974D0 (sv) 1990-12-12
NL9002720A (nl) 1991-07-16
ATA260690A (de) 1997-04-15
AU629777B2 (en) 1992-10-08
MY105328A (en) 1994-09-30
SE504922C2 (sv) 1997-05-26
US5081148A (en) 1992-01-14
SE9003974L (sv) 1991-06-23
IE64403B1 (en) 1995-08-09
GB8929076D0 (en) 1990-02-28
HK134693A (en) 1993-12-17
CA2032904A1 (en) 1991-06-23
OA09337A (fr) 1992-09-15
DK304190A (da) 1991-06-23
NL194717B (nl) 2002-09-02
JPH04364124A (ja) 1992-12-16
DK176168B1 (da) 2006-11-13

Similar Documents

Publication Publication Date Title
IT1246511B (it) Agenti bloccanti dell'effetto di edrf o della formazione di edrf per il trattamento di stati di shock
LV5824B4 (lv) Cilveku psihozes arstesanas panemiens
FI905531A7 (fi) 2-amino-6-n-propyyliamino-4,5,6,7-tetrahydrobentsotiatsolien transdermaalinen käyttö
FI912957A0 (fi) Metallitölkkirunko
MX19222A (es) Agentes ansioliticos bis-aza-biciclicos
IT8909356A0 (it) Procedimento di sferonizzazione e dispositivo per l'attuazione di detto procedimento
FI96327B (fi) Ferriittis-perliittisen teräksen käyttö
IT9021958A0 (it) Procedimento di purificazione dell'ammoniaca
IT1271567B (it) Procedimento per l'ulteriore trattamento di salcicce
IT1232822B (it) Impiego di progestina per il trattamento della osteoporosi
ITRM910519A0 (it) Collirio per il trattamento della ipertensione oculare
KR900015532U (ko) 일부인
KR920007613U (ko) 전신운동구
IT8922217A0 (it) Massaggiatore
FR2626769B1 (fr) Gant de massage
IT8929553V0 (it) Le rotte dell'ati
IT8847887A0 (it) Trattamento dell'infertilita'
IT8420712A1 (it) "Trattamento delle infezioni erpetiche"
KR900019997U (ko) 팔 가슴 운동구
KR930025096U (ko) 하체 단련용 슛팅 연습기
LV5400A3 (lv) Fiziskas darbspejas stimulejoss lidzeklis "Muldronats"
ITBO920166V0 (it) Apparecchiatura per l'esecuzione di trattamenti fitofarmaci
IT8823009A0 (it) Procedimento per la reversione della tossicita' della bromovinildesossiuridina (bvudr)
ITMI910954A0 (it) Metodo e dispositivo di indicazione biaurale della attivita' mioelettrica di due gruppi muscolari
IT231235Y1 (it) Dispositivo magnetico per un trattamento anticalcare dell'acqua

Legal Events

Date Code Title Description
0001 Granted
TA Fee payment date (situation as of event date), data collected since 19931001

Effective date: 19961227